Emphysema and Psychomotor hyperactivity

Summary:

Psychomotor hyperactivity is found among people with Emphysema, especially for people who are female, 60+ old.

The study analyzes which people have Psychomotor hyperactivity with Emphysema. It is created by eHealthMe based on reports of 15 people who have Emphysema from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Emphysema?

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs) is found to be associated with 1,063 drugs and 1,098 conditions by eHealthMe. Check the latest studies of Emphysema.

What is Psychomotor hyperactivity?

Psychomotor hyperactivity (feelings of extreme restlessness) is found to be associated with 886 drugs and 1,101 conditions by eHealthMe. Check the latest studies of Psychomotor hyperactivity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

15 people who have Emphysema and Psychomotor Hyperactivity are studied.

Would you have Psychomotor hyperactivity when you have Emphysema?

Gender of people who have Emphysema and experienced Psychomotor Hyperactivity *:

female: 73.33 %
male: 26.67 %

Age of people who have Emphysema and experienced Psychomotor Hyperactivity *:

Common co-existing conditions for these people *:

Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 8 people, 53.33%
Asthma: 4 people, 26.67%
Stress And Anxiety: 2 people, 13.33%
Depression: 2 people, 13.33%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 6.67%
Oedema Peripheral (superficial swelling): 1 person, 6.67%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 6.67%
Cardiac Disorder: 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%
High Blood Cholesterol: 1 person, 6.67%

Common drugs taken by these people *:

Common symptoms for these people *:

Cough: 6 people, 40.00%
Dyspnea (difficult or laboured breathing): 4 people, 26.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 13.33%
Confusional State: 2 people, 13.33%
Adverse Event: 2 people, 13.33%
Headache (pain in head): 2 people, 13.33%
Cataract (clouding of the lens inside the eye): 2 people, 13.33%
Chest Pain: 2 people, 13.33%
Stress And Anxiety: 2 people, 13.33%
Drowsiness: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Psychomotor hyperactivity?

- Check whether Psychomotor hyperactivity is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Emphysema (29,685 reports)
Psychomotor hyperactivity (20,459 reports)

All the drugs that are associated with Psychomotor hyperactivity:

Psychomotor hyperactivity (886 drugs)

All the conditions that are associated with Psychomotor hyperactivity:

Psychomotor hyperactivity (1,101 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Psychomotor hyperactivity and Emphysema, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.